DE NICOLA, Luca
 Distribuzione geografica
Continente #
EU - Europa 11.212
NA - Nord America 9.351
AS - Asia 7.804
SA - Sud America 1.392
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 29.879
Nazione #
US - Stati Uniti d'America 9.238
RU - Federazione Russa 4.487
SG - Singapore 2.763
IE - Irlanda 2.168
CN - Cina 1.823
HK - Hong Kong 1.445
BR - Brasile 1.187
UA - Ucraina 1.165
GB - Regno Unito 909
IT - Italia 703
DE - Germania 643
IN - India 477
TR - Turchia 328
FI - Finlandia 320
VN - Vietnam 310
SE - Svezia 299
KR - Corea 298
GR - Grecia 188
JP - Giappone 99
FR - Francia 90
AR - Argentina 83
AT - Austria 55
BD - Bangladesh 54
CA - Canada 46
BE - Belgio 43
MX - Messico 37
EC - Ecuador 36
CZ - Repubblica Ceca 29
NL - Olanda 28
ZA - Sudafrica 28
ID - Indonesia 27
IQ - Iraq 27
ES - Italia 25
PK - Pakistan 24
CO - Colombia 22
MA - Marocco 20
IR - Iran 17
TN - Tunisia 16
VE - Venezuela 16
CL - Cile 14
PY - Paraguay 14
UZ - Uzbekistan 14
PH - Filippine 13
MY - Malesia 11
PL - Polonia 11
IL - Israele 10
KZ - Kazakistan 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
KE - Kenya 9
EU - Europa 8
PE - Perù 8
UY - Uruguay 8
EG - Egitto 6
SA - Arabia Saudita 6
CH - Svizzera 5
RS - Serbia 5
SC - Seychelles 5
AU - Australia 4
BO - Bolivia 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
NI - Nicaragua 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
MK - Macedonia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
HN - Honduras 2
JO - Giordania 2
KH - Cambogia 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RW - Ruanda 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 29.859
Città #
Dublin 2.167
Jacksonville 1.747
Santa Clara 1.508
Hong Kong 1.443
Moscow 1.436
Chandler 1.119
Singapore 949
Chicago 473
Bengaluru 437
Princeton 343
Hefei 316
Seoul 289
Medford 279
Wilmington 269
Beijing 214
Roxbury 210
Boardman 207
Dallas 191
Ashburn 182
Ann Arbor 168
San Mateo 157
Falls Church 133
The Dalles 125
Ho Chi Minh City 119
Woodbridge 118
São Paulo 104
New York 101
Munich 96
Istanbul 95
Naples 88
Cambridge 85
Bremen 75
Hanoi 73
Des Moines 70
Nanjing 69
Jinan 62
Caserta 56
Los Angeles 51
Rio de Janeiro 44
Brussels 42
Norwalk 41
Nuremberg 41
Houston 38
Mountain View 35
Shenyang 35
Belo Horizonte 33
Napoli 33
Saint Petersburg 32
Zhengzhou 32
Rome 30
Guangzhou 29
Milan 28
Brno 27
Vienna 26
Tianjin 24
Helsinki 22
Changsha 21
Curitiba 20
Düsseldorf 19
Ercolano 19
Ningbo 19
Nanchang 18
Shanghai 18
Taizhou 18
Brooklyn 17
Campinas 17
Hangzhou 17
Turku 17
Sorocaba 15
Taiyuan 15
Da Nang 14
Falkenstein 14
Lanzhou 14
London 14
San Francisco 14
Biên Hòa 13
Dhaka 13
Johannesburg 13
Porto Alegre 13
Quito 13
Auburn Hills 12
Bologna 12
Haikou 12
Jiaxing 12
Seattle 12
Tashkent 12
Buenos Aires 11
Haiphong 11
Hebei 11
Salvador 11
Boston 10
Brasília 10
Frankfurt am Main 10
Manaus 10
Tokyo 10
Zanjan 10
Amsterdam 9
Asunción 9
Charlotte 9
Guayaquil 9
Totale 16.813
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 797
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 175
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 161
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 155
Empagliflozin in Patients with Chronic Kidney Disease 140
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 140
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 137
Amino acid loss during dialysis treatment 130
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 123
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 122
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 122
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 120
[Hyperuricaemia and Chronic Kidney Disease] 119
[Iron deficiency in ND-CKD: from diagnosis to treatment] 118
[Anti-diabetics and chronic kidney disease] 117
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 116
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 116
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 115
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 115
Daily nutrient intake in hemodialysis. 115
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 113
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 112
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 112
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 111
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 110
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 110
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 110
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 107
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 106
Acute renal and immunological effects of low-dose cyclosporin in humans 104
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 104
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 104
[Epidemiology and prognosis of chronic kidney disease in Italy] 104
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 103
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 103
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 103
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 103
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 102
Acute cyclosporine A nephrotoxicity 102
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 102
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 101
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 101
Epidemiology of chronic kidney disease in Italy: the CARHES study 100
Disfunzione renale nell’anziano: processo fisiologico o malattia? 99
Renal Disease 99
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 99
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 98
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 98
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 98
A new diuretic: the Atrial Natriuretic Peptide 98
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 97
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 97
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 96
Management of hypertension in chronic kidney disease 96
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 96
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 96
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 95
Management of hypertension in chronic kidney disease: the Italian multicenter study. 95
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 95
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 95
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 94
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 94
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 94
Epidemiology of CKD Regression in Patients under Nephrology Care 94
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 94
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 93
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 93
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 92
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 92
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 92
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 91
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 91
Epidemiology of chronic kidney disease in Italy 91
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 91
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 91
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 91
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis 90
Heart Failure in chronic kidney disease: from epidemiology to therapy. 90
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 90
Acute effects of low-dose cyclosporine on renal function in normal subjects 90
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 90
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 90
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 89
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 89
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 89
Reversibility of acute cyclosporine renal impairment by dopamine in healthy subjects 89
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 89
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 89
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 89
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 88
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 88
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 88
Acute effects of rapamycin on glomerular dynamics: a micropuncture study in the rat 88
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 87
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 87
Dopamine counteracts the acute renal effects of cyclosporine in normal subjects 87
Sodium removal by peritoneal dialysis: a systematic review and meta-analysis 87
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 86
Acute renal failure of unknown origin. Don't forget renal tuberculosis 86
Sindrome di Bartter: Un caso clinico 86
Totale 10.926
Categoria #
all - tutte 121.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.472


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.287 0 0 0 0 0 12 325 279 17 340 250 64
2021/20222.291 188 42 43 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/20269.819 887 1.204 1.168 1.078 1.769 3.713 0 0 0 0 0 0
Totale 30.329